Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




World's First Flexible Endoluminal Robotic System Enables Scar-Free and Less Invasive Surgical Procedures

By HospiMedica International staff writers
Posted on 05 Sep 2022

The world's first flexible endoluminal robotic system makes it possible for therapeutic endoscopists and surgeons to perform upper and lower gastrointestinal surgery less-invasively through a trans-oral or trans-anal approach. The robotic platform combines the flexibility of endoscopy that is able to navigate the curvature of patients' anatomy with instrumentation that allows the physician to use a conventional two-handed surgical technique.

ENDOQUEST Robotics (Houston, TX, USA) has developed the Endoluminal Surgical (ELS) System, the world's first flexible endoluminal robotic system which enables scar-free and less invasive surgical procedures. The system represents an innovative advance in minimally invasive surgery that combines the flexibility of conventional endoscopy with the advantages of traditional surgical techniques to improve control and outcomes. With this technology, therapeutic endoscopists and surgeons can perform a range of surgeries by accessing target disease sites directly through the body's existing lumens.

The ELS System design features a proprietary endoscope that works as a flexible and steerable overtube supporting the use of two surgical instruments and a videoscope. The minimally invasive procedures can be performed using only internal incisions that do not result in visible scarring. The enhanced capabilities of the robotic ELS System bring endoscopists and surgeons new levels of precision and control they need to use surgical techniques that were not previously possible.

The ELS System was named the winner of the Best Application Award in the 2022 Surgical Robotic Challenge based on results of a review of the use of the ELS System in ex vivo tissue models, including bovine colon and porcine esophagus, as well as a porcine Zenker's diverticula model, to assess basic functionality. Technical feasibility of colonic lesion resection was also explored. Results showed that the ELS system was able to function in a tortuous configuration with stable, smooth, and predictable movement of the flexible instrument end effectors and accessories could be efficiently exchanged without repositioning or interruption of the procedure. Tissue resection was possible in preclinical models, including simulated lesions in bovine colon. Myotomies were also successfully performed in porcine esophagus and Zenker's diverticula models.

"This achievement highlights the potential for EndoQuest's ELS System to allow for much broader adoption of endoluminal tissue resection techniques, ultimately enabling less invasive and scar-free endoluminal surgery to become more widely available to patients," said Kurt Azarbarzin, Chief Executive Officer of EndoQuest Robotics. "There is also clear potential to expand the applications of this technology further in endoscopic surgery in the years ahead."

Related Links:
ENDOQUEST Robotics 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Pediatric Phlebotomy Chair
2665M2 Extra Wide Pediatric Phlebotomy Chair
New
Needle-Free IV Connector Technology
Clave
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.